Details for Patent: 11,938,141
✉ Email this page to a colleague
Which drugs does patent 11,938,141 protect, and when does it expire?
Patent 11,938,141 protects WINLEVI and is included in one NDA.
This patent has seventy-two patent family members in twenty-four countries.
Drugs Protected by US Patent 11,938,141
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sun Pharm | WINLEVI | clascoterone | CREAM;TOPICAL | 213433-001 | Aug 26, 2020 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | Y | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,938,141
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Argentina | 072235 | ⤷ Subscribe | |||
Argentina | 111202 | ⤷ Subscribe | |||
Argentina | 111351 | ⤷ Subscribe | |||
Australia | 2008285784 | ⤷ Subscribe | |||
Brazil | PI0814163 | ⤷ Subscribe | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |